{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:22:30Z","timestamp":1790194950468,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274444"],"award-info":[{"award-number":["82274444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232269"],"award-info":[{"award-number":["7232269"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jad.2025.119435","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:14:28Z","timestamp":1748546068000},"page":"119435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database"],"prefix":"10.1016","volume":"388","author":[{"given":"Fangqing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiong","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119435_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-024-06529-5","article-title":"Aripiprazole and its adverse effects in the form of impulsive-compulsive behaviors: a systematic review of case reports","volume":"241","author":"Akbari","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jad.2025.119435_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620938595","article-title":"Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future","volume":"11","author":"Alomar","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.jad.2025.119435_bb0020","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11725","article-title":"Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database","volume":"79","author":"Amos","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12991-015-0075-x","article-title":"Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey","volume":"14","author":"Anderson","year":"2015","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0030","first-page":"231","article-title":"Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder","volume":"1","author":"Aouizerate","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.119435_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00059-012-3701-2","article-title":"Eosinophilic myocarditis","volume":"37","author":"Baandrup","year":"2012","journal-title":"Herz"},{"key":"10.1016\/j.jad.2025.119435_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1523\/JNEUROSCI.2225-15.2016","article-title":"Dopamine D3 receptors modulate the ability of win-paired cues to increase risky choice in a rat gambling task","volume":"36","author":"Barrus","year":"2016","journal-title":"J. Neurosci."},{"issue":"Suppl. 8","key":"10.1016\/j.jad.2025.119435_bb0045","first-page":"30","article-title":"Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety","volume":"66","author":"Blier","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00228-010-0952-9","article-title":"Restless legs syndrome due to aripiprazole","volume":"67","author":"Bola\u00f1os-Vergaray","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/acps.13567","article-title":"Antipsychotics and obsessive-compulsive disorder\/obsessive-compulsive symptoms: a pharmacovigilance study of the FDA adverse event reporting system","volume":"148","author":"Burk","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.119435_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/15563650.2021.1993242","article-title":"The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes","volume":"60","author":"Chiew","year":"2022","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.jad.2025.119435_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bcp.16152","article-title":"Management of serotonin syndrome (toxicity)","volume":"91","author":"Chiew","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0075","first-page":"2799","article-title":"Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics","volume":"173","author":"Christoffersen","year":"2011","journal-title":"Ugeskr. L\u00e6g."},{"key":"10.1016\/j.jad.2025.119435_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135555","article-title":"Role of 5-HT1A receptor-mediated serotonergic transmission in the medial prefrontal cortex in acute restraint stress-induced augmentation of rewarding memory of cocaine in mice","volume":"743","author":"Chu","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2025.119435_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115287","article-title":"Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: a territory-wide nested case-control study spanning two decades","volume":"326","author":"Chu","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.119435_bb0090","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neubiorev.2021.06.022","article-title":"Serotonergic regulation of the dopaminergic system: implications for reward-related functions","volume":"128","author":"Courtiol","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.119435_bb0095","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJM198104303041807","article-title":"Depression-dependent dyskinesias in two cases of manic-depressive illness","volume":"304","author":"Cutler","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.119435_bb0100","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11126-021-09892-0","article-title":"A comparative study of aripiprazole, olanzapine, and L-methylfolate augmentation in treatment resistant obsessive-compulsive disorder","volume":"92","author":"Dar","year":"2021","journal-title":"Psychiatry Q."},{"key":"10.1016\/j.jad.2025.119435_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/17512433.2024.2306223","article-title":"Metformin adverse event profile: a pharmacovigilance study based on the FDA adverse event reporting system (FAERS) from 2004 to 2022","volume":"17","author":"Du","year":"2024","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0110","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s10899-023-10251-w","article-title":"Looking at sex differences in gambling disorder: the predictive role of the early abandonment schema, gambling motives and alexithymia in depression","volume":"39","author":"Est\u00e9vez","year":"2023","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.jad.2025.119435_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eat.22985","article-title":"Associations between ovarian hormones and emotional eating across the menstrual cycle: do ovulatory shifts in hormones matter?","volume":"52","author":"Fowler","year":"2019","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.jad.2025.119435_bb0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ijnp\/pyac031","article-title":"Impulse control disorders by dopamine partial agonists: a pharmacovigilance-pharmacodynamic assessment through the FDA adverse event reporting system","volume":"25","author":"Fusaroli","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/PSY.0b013e318197a4d5","article-title":"Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women","volume":"71","author":"Goldbacher","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2025.119435_bb0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pnpbp.2017.11.004","article-title":"Side effect burden of antipsychotic drugs in real life - impact of gender and polypharmacy","volume":"82","author":"Iversen","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12888-024-06121-3","article-title":"Effects of decision making and impulsivity on the addictive features of non-suicidal self-injury behaviors in adolescents with depressive disorder","volume":"24","author":"Jiang","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/pcn.13615","article-title":"2024. Adjunctive brexpiprazole 1mg and 2mg daily for japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2\/3, randomized, double-blind (BLESS) study","volume":"78","author":"Kato","year":"2024","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"Suppl. 4","key":"10.1016\/j.jad.2025.119435_bb0145","first-page":"33","article-title":"Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia","volume":"61","author":"Keck","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1017\/S1461145707008310","article-title":"Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome","volume":"11","author":"Kikukawa","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/YCO.0b013e32832a16da","article-title":"Akathisia and second-generation antipsychotic drugs","volume":"22","author":"Kumar","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/2045125316672133","article-title":"Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature","volume":"7","author":"Kumar","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0165","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2147\/NSS.S421189","article-title":"Aripiprazole, a novel option in the management of restless legs syndrome (RLS) patients with augmentation and\/or severe RLS symptoms: a report of 4 cases","volume":"15","author":"Lee","year":"2023","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.jad.2025.119435_bb0170","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2204462","article-title":"Antidepressant augmentation versus switch in treatment-resistant geriatric depression","volume":"388","author":"Lenze","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.119435_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/appi.prcp.20190001","article-title":"Economic burden of treatment-resistant depression among patients hospitalized for major depressive disorder in the United States","volume":"1","author":"Lin","year":"2019","journal-title":"Psychiatr. Res. Clin. Pract."},{"key":"10.1016\/j.jad.2025.119435_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1017889","article-title":"Ocular adverse events associated with anti-VEGF therapy: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1017\/S1092852912001010","article-title":"Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex","volume":"18","author":"Marazziti","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.119435_bb0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clinthera.2023.10.015","article-title":"Estimating changes in weight and metabolic parameters before and after treatment with cariprazine: a retrospective study of electronic health records","volume":"46","author":"Masand","year":"2024","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2025.119435_bb0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11920-019-1015-2","article-title":"Epidemiological and clinical gender differences in OCD","volume":"21","author":"Mathes","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2025.119435_bb8020","series-title":"Psychiatric Genetics and Genomics","author":"McGuffin","year":"2002"},{"key":"10.1016\/j.jad.2025.119435_bb0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1017\/S1092852922001109","article-title":"Compulsive buying behavior and its association with emotional distress, depression, and impulsivity in general population: an online survey","volume":"28","author":"Mishra","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.119435_bb0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized clinical trial","volume":"318","author":"Mohamed","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2025.119435_bb0210","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1523\/JNEUROSCI.1459-22.2022","article-title":"D2\/3 agonist during learning potentiates cued risky choice","volume":"43","author":"Mortazavi","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2025.119435_bb0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/JCP.0b013e31820e3db6","article-title":"Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study","volume":"31","author":"Muscatello","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/ipj.ipj_182_20","article-title":"Aripiprazole-induced obsessive-compulsive symptoms","volume":"31","author":"Nafisa","year":"2022","journal-title":"Ind. Psychiatry J."},{"key":"10.1016\/j.jad.2025.119435_bb0225","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12796","article-title":"An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California poison control system","volume":"44","author":"Nguyen","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jad.2025.119435_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jagp.2023.11.006","article-title":"Relationship of hoarding and depression symptoms in older adults","volume":"32","author":"Nutley","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0245","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41386-020-00827-0","article-title":"Regulation of risky decision making by gonadal hormones in males and females","volume":"46","author":"Orsini","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.119435_bb0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.17116\/jnevro2020120041129","article-title":"Drug-induced restless legs syndrome","volume":"120","author":"Ostroumova","year":"2020","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.jad.2025.119435_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ecl.2024.10.010","article-title":"Exploring the bidirectional relationship between depression and obesity","volume":"54","author":"Park","year":"2025","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jad.2025.119435_bb0255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12883-019-1385-4","article-title":"Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis","volume":"19","author":"Patterson-Lomba","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jad.2025.119435_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020274","article-title":"Chemical insights into topical agents in intraocular pressure management: from glaucoma etiopathology to therapeutic approaches","volume":"16","author":"Patton","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jad.2025.119435_bb0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/YIC.0b013e32832e9b91","article-title":"Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study","volume":"24","author":"Pessina","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0270","first-page":"891","article-title":"Restless legs syndrome, periodic limb movements in sleep, and depression","volume":"28","author":"Picchietti","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.jad.2025.119435_bb0275","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jnnp.46.7.666","article-title":"State-dependent tardive dyskinesia in manic-depressive illness","volume":"46","author":"de Potter","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0280","article-title":"Psychotropic drugs for patients with glaucoma","volume":"185","author":"Povlsen","year":"2023","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.jad.2025.119435_bb0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0972-2327.150612","article-title":"Mild serotonin syndrome: a report of 12 cases","volume":"18","author":"Prakash","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jad.2025.119435_bb0295","article-title":"Age and sex differences in outpatient antipsychotic prescriptions for schizophrenia: a claims data study","author":"Ramin","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.119435_bb0300","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S1461145712001599","article-title":"Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature","volume":"16","author":"Rittmannsberger","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0305","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0310","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/da.21996","article-title":"Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial)","volume":"29","author":"Sayyah","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2025.119435_bb0320","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919873925","article-title":"Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions","volume":"12","author":"Scotton","year":"2019","journal-title":"Int. J. Tryptophan. Res."},{"key":"10.1016\/j.jad.2025.119435_bb0325","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1176\/appi.ajp.161.8.1324","article-title":"Gender differences in the prescribing of antipsychotic drugs","volume":"161","author":"Seeman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.05.008","article-title":"Men and women respond differently to antipsychotic drugs","volume":"163","author":"Seeman","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2025.119435_bb0340","article-title":"Long-term efficacy and tolerability of adjunctive aripiprazole for major depressive disorder: systematic review and Meta-analysis","volume":"23","author":"Seshadri","year":"2021","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jad.2025.119435_bb0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.049","article-title":"Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats","volume":"622","author":"da Silva","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2025.119435_bb0350","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1176\/appi.focus.140202","article-title":"Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes","volume":"14","author":"Spielmans","year":"2016","journal-title":"Focus"},{"key":"10.1016\/j.jad.2025.119435_bb0355","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.jcp.0000227809.60664.6d","article-title":"Quetiapine-induced obsessive-compulsive symptoms: a series of five cases","volume":"26","author":"Stamouli","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0360","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1139\/cjpp-2019-0381","article-title":"A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"98","author":"Talaei","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb0365","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.psc.2016.04.008","article-title":"Adverse effects of second-generation antipsychotics as adjuncts to antidepressants: are the risks worth the benefits?","volume":"39","author":"Thase","year":"2016","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2025.119435_bb0370","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4088\/JCP.14m09689","article-title":"Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study","volume":"76","author":"Thase","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0375","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4088\/JCP.14m09688","article-title":"Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants","volume":"76","author":"Thase","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0385","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/07067437241233965","volume":"69","author":"Therrien","year":"2024","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12888-016-0776-y","article-title":"Eosinophilic myocarditis during treatment with olanzapine - report of two possible cases","volume":"16","author":"Vang","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb8030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4088\/JCP.08m04269","article-title":"Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients","volume":"70","author":"Vulink","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119435_bb0395","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207151","article-title":"Quetiapine-induced myocarditis presenting as acute STEMI","volume":"2015","author":"Wassef","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jad.2025.119435_bb0400","first-page":"93","article-title":"A positive affective neuroendocrinology approach to reward and behavioral dysregulation","volume":"6","author":"Welker","year":"2015","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.119435_bb0240","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"10.1016\/j.jad.2025.119435_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256195","article-title":"Prevalence of metabolic syndrome and associated factors among psychiatric patients at university of Gondar comprehensive specialized hospital, Northwest Ethiopia","volume":"16","author":"Woldekidan","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2025.119435_bb0410","article-title":"Systematic analysis of adverse event reports for sex differences in adverse drug events","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.119435_bb0415","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.euroneuro.2021.05.001","article-title":"Do cariprazine and brexpiprazole cause impulse control symptoms? A case\/non-case study","volume":"50","author":"Zazu","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119435_bb8050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpsychires.2019.01.014","article-title":"Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: a network meta-analysis","volume":"111","author":"Zhou","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.119435_bb0420","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv060","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725008717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725008717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:33:49Z","timestamp":1778765629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725008717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":82,"alternative-id":["S0165032725008717"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119435","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119435"}}